20 May 2013
Keywords: astra/lexin, pharma, deal, lex032, evaluation, option, agreement
Article | 06 November 1995
- An evaluation and option agreement has been signed by Astra Merck
Inc and Lexin Pharmaceuticals to test LEX032, Lexin's recombinant ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 November 1995
© 2013 thepharmaletter.com